At Boehringer Ingelheim, we are investing into the power of computational biology and data sciences to accelerate the journey from scientific discoveries to breakthrough therapies.
Discover how Boehringer Ingelheim leverages translational science to bridge pre-clinical research and clinical development, enhancing patient outcomes in oncology. Learn about our patient-centric strategies, biomarker discovery, and collaborative efforts
Data protection In an increasingly digitalized world, the effective protection of personal data and the privacy of each individual plays an increasingly important role. For this reason, on May 25, 2018, the new EU General Data Protection Regulation GDPR
We improve patients' health and quality of life. This has been the central goal of the research-based pharmaceutical company Boehringer Ingelheim for 130 years.
Foot and mouth disease (FMD) is a highly contagious viral disease that affects cloven-hoofed animals such as cattle, pigs, sheep, and goats. Boehringer Ingelheim France is cooperating with its Kazakh partner QazBioPharm to manufacture vaccines.
Powerful teams are very often diverse. A good mixture of different personalities is beneficial, and it is for this reason that diversity in general has been encouraged for years at Boehringer Ingelheim.
Find out how you can keep your feline companion happy and healthy. 10 important questions about cat vaccination to help you make informed decisions about maintaining your cat’s health.
Boehringer Ingelheim is committed to transforming cancer care, investigating therapies that target cancer cells and boost the immune system for the benefit of patients.